Korro Bio (KRRO)

• Market cap: $125M
• 1 day: -0.15%
• 5 days: 24.39%
• 1 month: 65.34%
• 3 months: -63.85%
• 6 months: -14.07%
• Year to date: 65.34%
• 1 year: -60.27%
• 5 years: -99.44%
• 10 years: -98.06%
• Sector: Healthcare
• Industry: Biotechnology

About: Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Employees: 87